Institutional investors hold a majority ownership of CELG through the 85.14% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2013, these large investors purchased a net $4.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.4 Million shares of Celgene Corp
JENNISON ASSOCIATES LLC Bought 3.3 Million shares of Celgene Corp
MARSICO CAPITAL MANAGEMENT LLC Bought 2.7 Million shares of Celgene Corp